Consistent with these data, IHC analysis of tumor tissues revealed that tumor infiltration by CD8+ T cells and cytokine IFN-γ expression were elevated with TLR5 agonist monotherapy and combination therapy (Fig. 4C). The gene discussed is CD8A; the disease is neoplasm.